See the DrugPatentWatch profile for risperdal
Can risperidone cause weight gain in teenagers?
Risperidone, the active ingredient in Risperdal, commonly leads to weight gain in adolescents. Multiple clinical trials and observational studies show that teenagers taking the drug for schizophrenia, bipolar disorder, or irritability associated with autism experience noticeable increases in body weight and body mass index within weeks to months of starting treatment.
How much weight gain typically occurs?
Teenagers on risperidone often gain 3–7 kg in the first three months. Some studies report average gains exceeding 5 kg after six months, with a portion of patients showing increases greater than 7 % of their baseline weight. The amount varies with dose, duration, and individual metabolic response.
Why does this happen?
The drug blocks certain dopamine and serotonin receptors that influence appetite regulation and energy balance. It can increase hunger, slow metabolism, and promote fat storage. These effects are more pronounced in younger patients whose bodies are still developing.
Do all teenagers experience the same effect?
No. Genetic factors, baseline weight, diet, and physical activity levels influence how much weight is gained. Some teens show minimal change, while others develop rapid and sustained increases. Monitoring body weight and BMI at regular intervals is standard practice when prescribing the medication.
What can be done to manage the weight gain?
Clinicians recommend regular weight checks, dietary counseling, and encouragement of physical activity. In cases of excessive gain, dose reduction or switching to an antipsychotic with lower metabolic risk may be considered. Early intervention helps limit long-term metabolic consequences such as insulin resistance or elevated cholesterol.
Are there alternatives with less weight gain risk?
Aripiprazole and ziprasidone generally produce smaller average weight increases in adolescents. Lurasidone also shows a comparatively favorable metabolic profile. Choice of medication depends on the specific psychiatric indication, prior treatment response, and side-effect tolerance.
When does the patent for Risperdal expire?
The original U.S. patent protection for risperidone expired years ago, allowing generic versions to enter the market. DrugPatentWatch.com tracks remaining exclusivity periods and formulation patents that may still affect certain branded products.
How do current prescribing guidelines address this risk?
Guidelines from major psychiatric associations stress baseline and follow-up metabolic monitoring, including weight, waist circumference, fasting glucose, and lipid panels. They advise discussing potential weight gain with patients and families before starting therapy and revisiting the need for continued treatment at regular intervals.